Inhibitors of Bacterial Toxins Identified

Article

Using a novel yeast system, small molecule inhibitors of bacterial toxins have been identified, according to research published in the February issue of PLoS Genetics.

<p>THURSDAY, March 20 (HealthDay News) -- Using a novel yeast system, small molecule inhibitors of bacterial toxins have been identified, according to research published in the February issue of <i>PLoS Genetics</i>.</p><p>Anthony Arnoldo, from the University of Toronto in Ontario, Canada, and colleagues used a cell-based yeast phenotypic assay and a large-scale inhibitor screen to identify small molecules that could suppress the toxicity of 505 individual <i>Pseudomonas aeruginosa</i> genes.</p> <p>The researchers found that the inhibitor exosin inhibited the activity of Exoenzyme S, a toxin involved in Type III secretion. Exosin also protected mammalian cells against infection. Several yeast homologs of the known human targets of Exoenzyme S were also identified and found to be modified by the toxin.</p> <p>"Together, these observations validate our yeast-based approach for uncovering novel antibiotics," Arnoldo and colleagues conclude. "These compounds can be used as a starting point for new therapeutic treatments, and a similar strategy could be applied to a broad range of human pathogens like viruses or parasites."</p> <p><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2265467&rendertype=abstract"target="_new">Abstract</a><br/><a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2265467" target="_new">Full Text</a></p>

Copyright © 2008 <a href="http://www.physiciansbriefing.com/" target="_new">ScoutNews, LLC</a>. All rights reserved.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
John Browning, MD, provides practical skincare reminders ahead of summer season
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Discussing phase 3 data of Panzyga for PANS, with Michael Daines, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
© 2025 MJH Life Sciences

All rights reserved.